VCAM1 and metabolic dysfunction-associated steatotic liver disease: However, a recent study did not confirm an increased level of VEGF, as opposed to vascular cell adhesion molecule-1 (VCAM-1), a marker of endothelial activation, in the serum of NAFLD patients [17].